US Stock MarketDetailed Quotes

ITCI Intra-Cellular Therapies

Watchlist

65.000
-1.530-2.30%

Close May 17 16:00 ET

65.000
0.0000.00%

Post 16:02 ET

6.86BMarket Cap-56034P/E (TTM)

Intra-Cellular Therapies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

43.20%-34.12M

54.03%-124.2M

94.74%-2.06M

52.63%-25.27M

61.18%-36.8M

27.50%-60.07M

-4.10%-270.19M

46.45%-39.19M

32.69%-53.35M

-59.78%-94.79M

Net income from continuing operations

65.39%-15.25M

45.49%-139.67M

35.09%-28.58M

54.66%-24.26M

50.60%-42.78M

38.92%-44.05M

9.81%-256.26M

48.65%-44.03M

30.43%-53.51M

-25.98%-86.6M

Depreciation and amortization

-1.49%132K

-19.51%528K

-4.90%136K

-20.59%135K

-28.49%123K

-21.64%134K

23.08%656K

-2.05%143K

26.87%170K

36.51%172K

Other non cash items

4.55%23K

2.22%92K

4.55%23K

9.09%24K

4.55%23K

-8.33%22K

-49.72%90K

-35.29%22K

-43.59%22K

-57.69%22K

Change In working capital

-22.73%-30.52M

49.12%-29.58M

283.44%14.04M

-10.61%-13.29M

76.79%-5.46M

-66.35%-24.87M

-815.10%-58.14M

-303.00%-7.66M

-14.78%-12.02M

-1,988.67%-23.51M

-Change in receivables

-169.65%-17.14M

29.44%-38.83M

16.87%-11.35M

53.95%-6.71M

-1.94%-14.42M

49.86%-6.36M

-486.02%-55.03M

-323.81%-13.65M

-733.54%-14.56M

-826.87%-14.14M

-Change in inventory

88.71%-499K

-64.96%-26.35M

-2,154.49%-7.28M

-176.56%-1.09M

20.87%-13.55M

-8,138.18%-4.42M

-1,690.58%-15.97M

-247.49%-323K

457.14%1.43M

-8,962.96%-17.13M

-Change in prepaid assets

-127.34%-24M

77.43%-4.46M

1,261.62%12.35M

-166.43%-16.39M

381.04%10.14M

-18.26%-10.56M

-76.20%-19.75M

-126.48%-1.06M

15.37%-6.15M

53.11%-3.61M

-Change in payables and accrued expense

529.74%11.23M

28.77%41.26M

140.18%20.43M

51.03%10.99M

8.84%12.47M

-154.29%-2.61M

109.26%32.04M

202.42%8.5M

818.07%7.27M

7.07%11.45M

-Change in other current liabilities

87.55%-115K

-310.28%-1.21M

91.00%-101K

-4,500.00%-92K

-4.65%-90K

-151.79%-924K

428.00%574K

-2,016.98%-1.12M

95.24%-2K

-104.76%-86K

Cash from discontinued investing activities

Operating cash flow

43.20%-34.12M

54.03%-124.2M

94.74%-2.06M

52.63%-25.27M

61.18%-36.8M

27.50%-60.07M

-4.10%-270.19M

46.45%-39.19M

32.69%-53.35M

-59.78%-94.79M

Investing cash flow

Cash flow from continuing investing activities

198.28%16.18M

182.21%105.54M

-5.65%47.42M

-119.00%-20.17M

154.50%94.75M

94.89%-16.46M

-145.79%-128.37M

-2.42%50.26M

66.48%106.17M

-23.70%37.23M

Net PPE purchase and sale

----

65.42%-269K

-103.57%-1K

-129.06%-268K

----

-139.38%-778K

2,900.00%28K

62.14%-117K

-720.00%-123K

Net investment purchase and sale

198.28%16.18M

182.93%105.81M

-5.60%47.42M

-118.72%-19.9M

153.66%94.75M

94.88%-16.46M

-145.46%-127.6M

-2.48%50.24M

65.86%106.29M

-23.47%37.35M

Cash from discontinued investing activities

Investing cash flow

198.28%16.18M

182.21%105.54M

-5.65%47.42M

-119.00%-20.17M

154.50%94.75M

94.89%-16.46M

-145.79%-128.37M

-2.42%50.26M

66.48%106.17M

-23.70%37.23M

Financing cash flow

Cash flow from continuing financing activities

174.42%9.99M

-96.09%17.81M

37.36%3M

-54.35%2.58M

55.98%8.59M

-99.18%3.64M

3,851.38%455.16M

-72.37%2.19M

856.68%5.65M

247.91%5.5M

Net common stock issuance

----

--0

----

--433.72M

---7K

--0

Proceeds from stock option exercised by employees

174.42%9.99M

-16.93%17.81M

36.92%3M

-54.35%2.58M

55.98%8.59M

-55.00%3.64M

86.14%21.44M

-72.28%2.19M

856.68%5.65M

247.91%5.5M

Cash from discontinued financing activities

Financing cash flow

174.42%9.99M

-96.09%17.81M

37.36%3M

-54.35%2.58M

55.98%8.59M

-99.18%3.64M

3,851.38%455.16M

-72.37%2.19M

856.68%5.65M

247.91%5.5M

Net cash flow

Beginning cash position

-0.56%149.52M

60.36%150.37M

-26.22%101.15M

83.13%144.01M

-40.72%77.48M

60.36%150.37M

52.60%93.77M

27.51%137.11M

-35.77%78.64M

-0.52%130.7M

Current changes in cash

89.10%-7.95M

-101.50%-848K

264.83%48.37M

-173.29%-42.86M

227.80%66.53M

-297.37%-72.89M

75.13%56.6M

196.34%13.26M

492.33%58.47M

-481.68%-52.06M

End cash Position

82.72%141.57M

-0.56%149.52M

-26.22%101.15M

83.13%144.01M

-40.72%77.48M

60.36%150.37M

27.51%137.11M

-35.77%78.64M

Free cash flow

43.20%-34.12M

54.06%-124.47M

94.74%-2.06M

52.24%-25.54M

61.23%-36.8M

27.99%-60.07M

-4.27%-270.96M

46.48%-39.17M

32.81%-53.47M

-59.95%-94.92M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	43.20%-34.12M	54.03%-124.2M	94.74%-2.06M	52.63%-25.27M	61.18%-36.8M	27.50%-60.07M	-4.10%-270.19M	46.45%-39.19M	32.69%-53.35M	-59.78%-94.79M
Net income from continuing operations	65.39%-15.25M	45.49%-139.67M	35.09%-28.58M	54.66%-24.26M	50.60%-42.78M	38.92%-44.05M	9.81%-256.26M	48.65%-44.03M	30.43%-53.51M	-25.98%-86.6M
Depreciation and amortization	-1.49%132K	-19.51%528K	-4.90%136K	-20.59%135K	-28.49%123K	-21.64%134K	23.08%656K	-2.05%143K	26.87%170K	36.51%172K
Other non cash items	4.55%23K	2.22%92K	4.55%23K	9.09%24K	4.55%23K	-8.33%22K	-49.72%90K	-35.29%22K	-43.59%22K	-57.69%22K
Change In working capital	-22.73%-30.52M	49.12%-29.58M	283.44%14.04M	-10.61%-13.29M	76.79%-5.46M	-66.35%-24.87M	-815.10%-58.14M	-303.00%-7.66M	-14.78%-12.02M	-1,988.67%-23.51M
-Change in receivables	-169.65%-17.14M	29.44%-38.83M	16.87%-11.35M	53.95%-6.71M	-1.94%-14.42M	49.86%-6.36M	-486.02%-55.03M	-323.81%-13.65M	-733.54%-14.56M	-826.87%-14.14M
-Change in inventory	88.71%-499K	-64.96%-26.35M	-2,154.49%-7.28M	-176.56%-1.09M	20.87%-13.55M	-8,138.18%-4.42M	-1,690.58%-15.97M	-247.49%-323K	457.14%1.43M	-8,962.96%-17.13M
-Change in prepaid assets	-127.34%-24M	77.43%-4.46M	1,261.62%12.35M	-166.43%-16.39M	381.04%10.14M	-18.26%-10.56M	-76.20%-19.75M	-126.48%-1.06M	15.37%-6.15M	53.11%-3.61M
-Change in payables and accrued expense	529.74%11.23M	28.77%41.26M	140.18%20.43M	51.03%10.99M	8.84%12.47M	-154.29%-2.61M	109.26%32.04M	202.42%8.5M	818.07%7.27M	7.07%11.45M
-Change in other current liabilities	87.55%-115K	-310.28%-1.21M	91.00%-101K	-4,500.00%-92K	-4.65%-90K	-151.79%-924K	428.00%574K	-2,016.98%-1.12M	95.24%-2K	-104.76%-86K
Cash from discontinued investing activities
Operating cash flow	43.20%-34.12M	54.03%-124.2M	94.74%-2.06M	52.63%-25.27M	61.18%-36.8M	27.50%-60.07M	-4.10%-270.19M	46.45%-39.19M	32.69%-53.35M	-59.78%-94.79M
Investing cash flow
Cash flow from continuing investing activities	198.28%16.18M	182.21%105.54M	-5.65%47.42M	-119.00%-20.17M	154.50%94.75M	94.89%-16.46M	-145.79%-128.37M	-2.42%50.26M	66.48%106.17M	-23.70%37.23M
Net PPE purchase and sale	----	65.42%-269K	-103.57%-1K	-129.06%-268K	----	----	-139.38%-778K	2,900.00%28K	62.14%-117K	-720.00%-123K
Net investment purchase and sale	198.28%16.18M	182.93%105.81M	-5.60%47.42M	-118.72%-19.9M	153.66%94.75M	94.88%-16.46M	-145.46%-127.6M	-2.48%50.24M	65.86%106.29M	-23.47%37.35M
Cash from discontinued investing activities
Investing cash flow	198.28%16.18M	182.21%105.54M	-5.65%47.42M	-119.00%-20.17M	154.50%94.75M	94.89%-16.46M	-145.79%-128.37M	-2.42%50.26M	66.48%106.17M	-23.70%37.23M
Financing cash flow
Cash flow from continuing financing activities	174.42%9.99M	-96.09%17.81M	37.36%3M	-54.35%2.58M	55.98%8.59M	-99.18%3.64M	3,851.38%455.16M	-72.37%2.19M	856.68%5.65M	247.91%5.5M
Net common stock issuance	----	--0	--0	--0	----	----	--433.72M	---7K	--0	--0
Proceeds from stock option exercised by employees	174.42%9.99M	-16.93%17.81M	36.92%3M	-54.35%2.58M	55.98%8.59M	-55.00%3.64M	86.14%21.44M	-72.28%2.19M	856.68%5.65M	247.91%5.5M
Cash from discontinued financing activities
Financing cash flow	174.42%9.99M	-96.09%17.81M	37.36%3M	-54.35%2.58M	55.98%8.59M	-99.18%3.64M	3,851.38%455.16M	-72.37%2.19M	856.68%5.65M	247.91%5.5M
Net cash flow
Beginning cash position	-0.56%149.52M	60.36%150.37M	-26.22%101.15M	83.13%144.01M	-40.72%77.48M	60.36%150.37M	52.60%93.77M	27.51%137.11M	-35.77%78.64M	-0.52%130.7M
Current changes in cash	89.10%-7.95M	-101.50%-848K	264.83%48.37M	-173.29%-42.86M	227.80%66.53M	-297.37%-72.89M	75.13%56.6M	196.34%13.26M	492.33%58.47M	-481.68%-52.06M
End cash Position	82.72%141.57M	-0.56%149.52M	-0.56%149.52M	-26.22%101.15M	83.13%144.01M	-40.72%77.48M	60.36%150.37M	60.36%150.37M	27.51%137.11M	-35.77%78.64M
Free cash flow	43.20%-34.12M	54.06%-124.47M	94.74%-2.06M	52.24%-25.54M	61.23%-36.8M	27.99%-60.07M	-4.27%-270.96M	46.48%-39.17M	32.81%-53.47M	-59.95%-94.92M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall